| Primary reason for reoperationa . | Primary augmentation (n = 29) . | Revisional augmentation (n = 29) . | Overall augmentation (n = 58) . |
|---|---|---|---|
| Infection | 2 (6.9%) | 1 (3.4%) | 3 (5.2%) |
| Capsular contracture | 3 (10.3%) | 6 (20.7%) | 9 (15.5%) |
| Implant extrusion | 0 | 1 (3.4%) | 1 (1.7%) |
| Hematoma | 3 (10.3%) | 4 (13.8%) | 7 (12.1%) |
| Breast pain | 0 | 1 (3.4%) | 1 (1.7%) |
| Implant malposition | 13 (44.8%) | 2 (6.9%) | 15 (25.9%) |
| Upper pole fullness | 0 | 1 (3.4%) | 1 (1.7%) |
| Animation deformity | 1 (3.4%) | 0 | 1 (1.7%) |
| Asymmetry | 1 (3.4%) | 1 (3.4%) | 2 (3.4%) |
| Ptosis | 1 (3.4%) | 5 (17.2%) | 6 (10.3%) |
| Hypertrophic/abnormal scarring | 2 (6.9%) | 1 (3.4%) | 3 (5.2%) |
| Mass/cyst/lump | 1 (3.4%) | 0 | 1 (1.7%) |
| Size change/patient choice | 2 (6.9%) | 6 (20.7%) | 8 (13.8%) |
| Primary reason for reoperationa . | Primary augmentation (n = 29) . | Revisional augmentation (n = 29) . | Overall augmentation (n = 58) . |
|---|---|---|---|
| Infection | 2 (6.9%) | 1 (3.4%) | 3 (5.2%) |
| Capsular contracture | 3 (10.3%) | 6 (20.7%) | 9 (15.5%) |
| Implant extrusion | 0 | 1 (3.4%) | 1 (1.7%) |
| Hematoma | 3 (10.3%) | 4 (13.8%) | 7 (12.1%) |
| Breast pain | 0 | 1 (3.4%) | 1 (1.7%) |
| Implant malposition | 13 (44.8%) | 2 (6.9%) | 15 (25.9%) |
| Upper pole fullness | 0 | 1 (3.4%) | 1 (1.7%) |
| Animation deformity | 1 (3.4%) | 0 | 1 (1.7%) |
| Asymmetry | 1 (3.4%) | 1 (3.4%) | 2 (3.4%) |
| Ptosis | 1 (3.4%) | 5 (17.2%) | 6 (10.3%) |
| Hypertrophic/abnormal scarring | 2 (6.9%) | 1 (3.4%) | 3 (5.2%) |
| Mass/cyst/lump | 1 (3.4%) | 0 | 1 (1.7%) |
| Size change/patient choice | 2 (6.9%) | 6 (20.7%) | 8 (13.8%) |
aIf multiple reasons were provided, then primary was assigned in the order that it appears in the table. Primary reasons that were not reported (eg, rupture) do not appear on this table.
| Primary reason for reoperationa . | Primary augmentation (n = 29) . | Revisional augmentation (n = 29) . | Overall augmentation (n = 58) . |
|---|---|---|---|
| Infection | 2 (6.9%) | 1 (3.4%) | 3 (5.2%) |
| Capsular contracture | 3 (10.3%) | 6 (20.7%) | 9 (15.5%) |
| Implant extrusion | 0 | 1 (3.4%) | 1 (1.7%) |
| Hematoma | 3 (10.3%) | 4 (13.8%) | 7 (12.1%) |
| Breast pain | 0 | 1 (3.4%) | 1 (1.7%) |
| Implant malposition | 13 (44.8%) | 2 (6.9%) | 15 (25.9%) |
| Upper pole fullness | 0 | 1 (3.4%) | 1 (1.7%) |
| Animation deformity | 1 (3.4%) | 0 | 1 (1.7%) |
| Asymmetry | 1 (3.4%) | 1 (3.4%) | 2 (3.4%) |
| Ptosis | 1 (3.4%) | 5 (17.2%) | 6 (10.3%) |
| Hypertrophic/abnormal scarring | 2 (6.9%) | 1 (3.4%) | 3 (5.2%) |
| Mass/cyst/lump | 1 (3.4%) | 0 | 1 (1.7%) |
| Size change/patient choice | 2 (6.9%) | 6 (20.7%) | 8 (13.8%) |
| Primary reason for reoperationa . | Primary augmentation (n = 29) . | Revisional augmentation (n = 29) . | Overall augmentation (n = 58) . |
|---|---|---|---|
| Infection | 2 (6.9%) | 1 (3.4%) | 3 (5.2%) |
| Capsular contracture | 3 (10.3%) | 6 (20.7%) | 9 (15.5%) |
| Implant extrusion | 0 | 1 (3.4%) | 1 (1.7%) |
| Hematoma | 3 (10.3%) | 4 (13.8%) | 7 (12.1%) |
| Breast pain | 0 | 1 (3.4%) | 1 (1.7%) |
| Implant malposition | 13 (44.8%) | 2 (6.9%) | 15 (25.9%) |
| Upper pole fullness | 0 | 1 (3.4%) | 1 (1.7%) |
| Animation deformity | 1 (3.4%) | 0 | 1 (1.7%) |
| Asymmetry | 1 (3.4%) | 1 (3.4%) | 2 (3.4%) |
| Ptosis | 1 (3.4%) | 5 (17.2%) | 6 (10.3%) |
| Hypertrophic/abnormal scarring | 2 (6.9%) | 1 (3.4%) | 3 (5.2%) |
| Mass/cyst/lump | 1 (3.4%) | 0 | 1 (1.7%) |
| Size change/patient choice | 2 (6.9%) | 6 (20.7%) | 8 (13.8%) |
aIf multiple reasons were provided, then primary was assigned in the order that it appears in the table. Primary reasons that were not reported (eg, rupture) do not appear on this table.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
